Prevention of generalized reactions to contrast media: a consensus report and guidelines

被引:87
作者
Morcos, SK [1 ]
Thomsen, HS
Webb, JAW
机构
[1] No Gen Hosp NHS Trust, Dept Diagnost Imaging, Sheffield S5 7AY, S Yorkshire, England
[2] Univ Copenhagen, Herlev Hosp, Dept Diagnost Radiol, DK-2730 Herlev, Denmark
[3] St Bartholomews Hosp, Dept Diagnost Radiol, London EC1A 7BE, England
关键词
contrast media; consensus; generalized reaction; risk factors; prophylaxis; guidelines;
D O I
10.1007/s003300000778
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The aim of this study was to document, using consensus methodology, current practice for prevention of generalized reactions to contrast media. to identify areas where there is disagreement or confusion and to draw up guidelines for reducing the risk of generalized contrast media reactions based on the survey and a review of the literature. A document with 165 questions was mailed to 202 members of the European Society of Urogenital Radiology. The questions covered risk factors and prophylactic measures for generalized contrast media reactions. Sixty-eight members (34%) responded. The majority indicated that a history of moderate and severe reaction(s) to contrast media and asthma are important risk factors. The survey also indicated that patients with risk factors should receive non-ionic contrast media. In patients at high risk of reaction, if the examination is deemed absolutely necessary, a resuscitation team should be available at the time of the procedure. The majority (91%) used corticosteroid prophylaxis given at least 11 h before contrast medium to patients at increased risk of reaction. The frequency of the dosage varied from one to three times. Fifty-five percent also use antihistamine Hl, mainly administered orally and once. Antihistamine H2 and ephedrine are rarely used. All essential drugs are available on the emergency resuscitation trolley. Patients with risk factors are observed up to 30 min by 48% and up to 60 min by 43% of the responders. Prophylactic measures are not taken before extravascular use of contrast media. Prophylactic drugs are given to patients with a history of moderate or severe generalized reaction to contrast media. In patients with asthma, opinion is divided with only half of the responders giving prophylactic drugs. Aspirin, beta -blockers, interleukin-2 and non-steroid anti-inflammatory drugs are not considered risk factors and therefore are not stopped before injection of contrast media. The survey showed some variability in rating of risk factors for generalized contrast medium reactions, and marked variability in the prophylactic measures used. There remain major areas of uncertainty, and there is insufficient data in the literature to guide practice. Some simple guidelines for prophylaxis of generalized contrast medium reactions are proposed.
引用
收藏
页码:1720 / 1728
页数:9
相关论文
共 36 条
[1]   THE RELEASE OF HISTAMINE FROM HUMAN BASOPHILS BY RADIOLOGICAL CONTRAST AGENTS [J].
ASSEM, ESK ;
BRAY, K ;
DAWSON, P .
BRITISH JOURNAL OF RADIOLOGY, 1983, 56 (669) :647-652
[2]  
Bush Jr WH, 1999, RADIOLOGY LIFE SUPPO, P31
[3]   DELAYED-REACTIONS TO CONTRAST-MEDIA AFTER INTERLEUKIN-2 IMMUNOTHERAPY [J].
CHOYKE, PL ;
MILLER, DL ;
LOTZE, MT ;
WHITEIS, JM ;
EBBITT, B ;
ROSENBERG, SA .
RADIOLOGY, 1992, 183 (01) :111-114
[4]   USE OF LOW-OSMOLAR AGENTS AND PREMEDICATION TO REDUCE THE FREQUENCY OF ADVERSE REACTIONS TO RADIOGRAPHIC CONTRAST-MEDIA - A SURVEY OF THE SOCIETY-OF-URORADIOLOGY [J].
COHAN, RH ;
ELLIS, JH ;
DUNNICK, NR .
RADIOLOGY, 1995, 194 (02) :357-364
[5]   IS THERE A ROLE FOR CORTICOSTEROID PROPHYLAXIS IN PATIENTS AT INCREASED RISK OF ADVERSE REACTIONS TO INTRAVASCULAR CONTRAST AGENTS [J].
DAWSON, P ;
SIDHU, PS .
CLINICAL RADIOLOGY, 1993, 48 (04) :225-226
[6]  
DORE C, 1994, CLIN RADIOL, V49, P583, DOI 10.1016/S0009-9260(05)82946-0
[7]  
DORE CJ, 1995, CLIN RADIOL, V50, P198, DOI 10.1016/S0009-9260(05)83060-0
[8]   COST, CORTICOSTEROIDS, AND CONTRAST-MEDIA [J].
DUNNICK, NR ;
COHAN, RH .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1994, 162 (03) :527-529
[9]  
EVAN PW, 1997, PRESCRIBERS J, V37, P125
[10]   ATYPICAL CONTRAST REACTIONS ASSOCIATED WITH SYSTEMIC INTERLEUKIN-2 THERAPY [J].
FISHMAN, JE ;
ABERLE, DR ;
MOLDAWER, NP ;
BELLDEGRUN, A ;
FIGLIN, RA .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1991, 156 (04) :833-834